Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
2
50%
Ph not_applicable
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Alcohol & Men's Sexual Risk Behaviors

NCT06158880
completednot_applicable

Men's Sexual Risk Behaviors: Alcohol, Sexual Aggression, and Emotional Factors

NCT03900650
completedphase_1

Neuroendocrine Response to Oral Alcohol Administration

NCT03165942
completedphase_1

Dopamine Release in the Human Brain Following Alcohol Administration

NCT01638364

Clinical Trials (4)

Showing 4 of 4 trials
NCT06158880Not Applicable

Alcohol & Men's Sexual Risk Behaviors

Recruiting
NCT03900650Not Applicable

Men's Sexual Risk Behaviors: Alcohol, Sexual Aggression, and Emotional Factors

Completed
NCT03165942Phase 1

Neuroendocrine Response to Oral Alcohol Administration

Completed
NCT01638364Phase 1

Dopamine Release in the Human Brain Following Alcohol Administration

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4